Clinical trial
A Phase I/II Open-label Study of Clofarabine in Patients With Relapsed or Refractory Diffuse Large Cell B-Cell NHL
NCT00156013 is registered in ClinicalTrials.gov with Oncology Specialists, S.C. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Open-label Study of Clofarabine in Patients With Relapsed or Refractory Diffuse Large Cell B-Cell NHL
- Lead sponsor
- Oncology Specialists, S.C.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2005
- Completion date
- April 30, 2010
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.